Brief: Reviva Pharmaceuticals Announces Pricing Of $10 Million Public Offering At $1.50 Per Share
March 18 (Reuters) - Reviva Pharmaceuticals Holdings Inc RVPH.O: REVIVA PHARMACEUTICALS HOLDINGS, INC. ANNOUNCES PRICING OF $10 MILLION PUBLIC OFFERING REVIVA PHARMACEUTICALS HOLDINGS INC - PRICES PUBLIC OFFERING OF 6,666,667 SHARES AND WARRANTS AT $1.50 PER SHARE Source text: ID:nGNX86d48N Further company coverage: RVPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Reviva Pharmaceuticals Holdings
See all newsReviva Pharmaceuticals Q1 net loss narrows on lower expenses
Brief: Reviva Pharmaceuticals Holdings Inc - To Be Delisted From Nasdaq Trading Suspended As Of May 14, 2026 - SEC Filing
Brief: Reviva Reports Full Year 2025 Financial Results And Recent Business Highlights
Reviva Pharmaceuticals' 2025 net loss narrows on lower R&D spending
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture